LINFOMAS Y TRASPLANTES
University of Virginia
Charlottesville, Estados UnidosUniversity of Virginia-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies
European Journal of Cancer, Vol. 174, pp. S31-S32